Co-Authors
This is a "connection" page, showing publications co-authored by Natalie Thornburg and Alicia Fry.
Connection Strength
0.821
-
Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States. J Infect Dis. 2021 09 01; 224(5):771-776.
Score: 0.241
-
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020 Jul 21.
Score: 0.223
-
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020. Clin Infect Dis. 2021 11 16; 73(10):1831-1839.
Score: 0.061
-
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey. Clin Infect Dis. 2021 11 02; 73(9):e3120-e3123.
Score: 0.061
-
A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time. Clin Infect Dis. 2021 10 05; 73(7):e1841-e1849.
Score: 0.061
-
Detection of SARS-CoV-2 on Surfaces in Households of Persons with COVID-19. Int J Environ Res Public Health. 2021 08 02; 18(15).
Score: 0.060
-
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Intern Med. 2021 04 01; 181(4):450-460.
Score: 0.059
-
Investigation and Serologic Follow-Up of Contacts of an Early Confirmed Case-Patient with COVID-19, Washington, USA. Emerg Infect Dis. 2020 Aug; 26(8):1671-1678.
Score: 0.055